Pica aquí para ver Newsletter
Organizada : Primary Care Diabetes Europe - PCDE (pica aquí para tener toda la información del evento)
Fecha límite de presentación de resúmenes es Lunes, 03 de marzo 2014.
Fecha límite de presentación de resúmenes es Lunes, 03 de marzo 2014.
Se pueden enviar resúmenes de nuevas investigaciones en el campo de la DM2 y la Atención Primaria, incluso algún trabajo ya publicado o presentado por la EASD, WONCA, etc.
Los participantes presentarán y compartirán sus resultados de investigación durante sesiones interactivas.
Los 5 primeros carteles seleccionados se presentarán en una sesión plenaria.
Los 5 primeros carteles seleccionados se presentarán en una sesión plenaria.
Los resúmenes serán publicados en la revista propia del PCDE Primary Care Diabetes journal (Medline, Scopus, Science Citation Index (1.6) y PsycINFO indexados)
Programa:
Type 2 Diabetes Management:
Orals and injectables: Guy Rutten (Netherlands)
Combination therapy: Manel Mata (Spain)
Orals and injectables: Guy Rutten (Netherlands)
Combination therapy: Manel Mata (Spain)
Social Media, Internet 2.0:
Line Kleinebreil (France), Belen Benito (Spain)
Line Kleinebreil (France), Belen Benito (Spain)
Multimorbidity:
Type 2 diabetes and mental healt: Frans Pouwer (Netherlands)
Type 2 diabetes and cancer: Manel Mata (Spain)
Type 2 diabetes and syndemia: Carmen Ioana Jarca (Spain)
Type 2 diabetes and chronic osteo artritis: Mehmet Sargin (Turkey)
Diabetes and hypertension: are blood pressure target levels evidence-based?
Arno Hoes (Netherlands)
Type 2 diabetes and mental healt: Frans Pouwer (Netherlands)
Type 2 diabetes and cancer: Manel Mata (Spain)
Type 2 diabetes and syndemia: Carmen Ioana Jarca (Spain)
Type 2 diabetes and chronic osteo artritis: Mehmet Sargin (Turkey)
Diabetes and hypertension: are blood pressure target levels evidence-based?
Arno Hoes (Netherlands)
Comunication skills:
Hilde Bastiaens (Belgium)
Hilde Bastiaens (Belgium)
Debate pro Vs con -PRO sulphonylurea:
Kamlesh Khunti (UK),
Martin Hadley-Brown (UK)
Kamlesh Khunti (UK),
Martin Hadley-Brown (UK)
Kidney:
Diagnosis and follow up: Imre Rurik (Hungary)
Drug interaction in kidney failure: Imre Rurik (Hungary)
Prevention: Xavier Cos, Antonio Rodríguez (Spain)
Diagnosis and follow up: Imre Rurik (Hungary)
Drug interaction in kidney failure: Imre Rurik (Hungary)
Prevention: Xavier Cos, Antonio Rodríguez (Spain)
Self monitoring blood glucose:
Guusje Neijens (Netherlands)
Guusje Neijens (Netherlands)
Cardio Metabolic Challenges:
Hypertension: Richard Hobbs (UK)
Smoking cessation: Carmen Cabezas (Spain)
Physical activity: Laura Brugnara (Spain)
Dyslipidemia: Richard Hobbs (UK)
Heart failure in diabetes: Arno Hoes (Netherlands)
Hypertension: Richard Hobbs (UK)
Smoking cessation: Carmen Cabezas (Spain)
Physical activity: Laura Brugnara (Spain)
Dyslipidemia: Richard Hobbs (UK)
Heart failure in diabetes: Arno Hoes (Netherlands)
New drugs:
Safety issues and cost efficiency: Luc Martinez (France), Eugene Hughes (UK)
Safety issues and cost efficiency: Luc Martinez (France), Eugene Hughes (UK)